CN111455115A - 一种基于rt-pcr及毛细电泳的同步检测19种脑炎脑膜炎病原体的试剂盒及检测方法 - Google Patents
一种基于rt-pcr及毛细电泳的同步检测19种脑炎脑膜炎病原体的试剂盒及检测方法 Download PDFInfo
- Publication number
- CN111455115A CN111455115A CN202010461604.1A CN202010461604A CN111455115A CN 111455115 A CN111455115 A CN 111455115A CN 202010461604 A CN202010461604 A CN 202010461604A CN 111455115 A CN111455115 A CN 111455115A
- Authority
- CN
- China
- Prior art keywords
- pcr
- internal reference
- capillary electrophoresis
- dna
- encephalitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000052769 pathogen Species 0.000 title claims abstract description 41
- 201000009906 Meningitis Diseases 0.000 title claims abstract description 40
- 206010014599 encephalitis Diseases 0.000 title claims abstract description 36
- 238000003757 reverse transcription PCR Methods 0.000 title claims abstract description 34
- 238000005251 capillar electrophoresis Methods 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 35
- 238000001514 detection method Methods 0.000 claims abstract description 31
- 230000003321 amplification Effects 0.000 claims abstract description 24
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 24
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 23
- 239000013642 negative control Substances 0.000 claims abstract description 9
- 239000013641 positive control Substances 0.000 claims abstract description 9
- 108090000790 Enzymes Proteins 0.000 claims abstract description 8
- 102000004190 Enzymes Human genes 0.000 claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 24
- 108020004707 nucleic acids Proteins 0.000 claims description 22
- 102000039446 nucleic acids Human genes 0.000 claims description 22
- 201000010099 disease Diseases 0.000 claims description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
- 238000004458 analytical method Methods 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 2
- 239000013599 cloning vector Substances 0.000 claims 1
- 108091036078 conserved sequence Proteins 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 8
- 206010011409 Cross infection Diseases 0.000 abstract description 4
- 206010029803 Nosocomial infection Diseases 0.000 abstract description 4
- 239000000523 sample Substances 0.000 description 25
- 230000001717 pathogenic effect Effects 0.000 description 10
- 241000709661 Enterovirus Species 0.000 description 9
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 7
- 238000007481 next generation sequencing Methods 0.000 description 7
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 6
- 241000193998 Streptococcus pneumoniae Species 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 6
- 201000007336 Cryptococcosis Diseases 0.000 description 5
- 241000221204 Cryptococcus neoformans Species 0.000 description 5
- 241000606768 Haemophilus influenzae Species 0.000 description 5
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 5
- 230000007547 defect Effects 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 241000186781 Listeria Species 0.000 description 4
- 241000711386 Mumps virus Species 0.000 description 4
- 241000588650 Neisseria meningitidis Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 229940047650 haemophilus influenzae Drugs 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010027202 Meningitis bacterial Diseases 0.000 description 3
- 206010027260 Meningitis viral Diseases 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 201000009904 bacterial meningitis Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002595 magnetic resonance imaging Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 201000010044 viral meningitis Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 2
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- 241000701027 Human herpesvirus 6 Species 0.000 description 2
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 2
- 206010027236 Meningitis fungal Diseases 0.000 description 2
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 206010034960 Photophobia Diseases 0.000 description 2
- 241000700584 Simplexvirus Species 0.000 description 2
- 241000193985 Streptococcus agalactiae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 201000010056 fungal meningitis Diseases 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000009593 lumbar puncture Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- 208000014912 Central Nervous System Infections Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 241001466953 Echovirus Species 0.000 description 1
- 241000617590 Escherichia coli K1 Species 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010027253 Meningitis pneumococcal Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010021888 Nervous system infections Diseases 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 206010054956 Phonophobia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000606651 Rickettsiales Species 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 208000002552 acute disseminated encephalomyelitis Diseases 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003210 demyelinating effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229940045808 haemophilus influenzae type b Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 208000020942 non-infectious meningitis Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 208000004593 pneumococcal meningitis Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010461604.1A CN111455115A (zh) | 2020-05-27 | 2020-05-27 | 一种基于rt-pcr及毛细电泳的同步检测19种脑炎脑膜炎病原体的试剂盒及检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010461604.1A CN111455115A (zh) | 2020-05-27 | 2020-05-27 | 一种基于rt-pcr及毛细电泳的同步检测19种脑炎脑膜炎病原体的试剂盒及检测方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111455115A true CN111455115A (zh) | 2020-07-28 |
Family
ID=71677978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010461604.1A Pending CN111455115A (zh) | 2020-05-27 | 2020-05-27 | 一种基于rt-pcr及毛细电泳的同步检测19种脑炎脑膜炎病原体的试剂盒及检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111455115A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114672593A (zh) * | 2022-03-25 | 2022-06-28 | 江苏先声医学诊断有限公司 | 用于中枢神经感染病原体核酸检测的引物组、产品及应用 |
CN116042921A (zh) * | 2022-12-28 | 2023-05-02 | 圣湘生物科技股份有限公司 | 检测病毒性脑炎病毒的组合物、试剂盒、方法及其用途 |
CN116144811A (zh) * | 2022-12-21 | 2023-05-23 | 迪飞医学科技(南京)有限公司 | 用于检测脑脊液病原的多重引物组、方法和试剂盒 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1420123A (zh) * | 2001-11-16 | 2003-05-28 | 晶碁生化科技股份有限公司 | 用于诊断脑膜炎病原菌的核酸序列、方法及套组 |
CN102994650A (zh) * | 2012-06-21 | 2013-03-27 | 海尔施生物医药股份有限公司 | 一种基于毛细电泳的致脑炎病毒多重基因检测方法 |
CN103074448A (zh) * | 2013-01-25 | 2013-05-01 | 海尔施生物医药股份有限公司 | 一种同步检测二十三种脑炎脑膜炎病原体的试剂盒及其检测方法 |
CN105385787A (zh) * | 2015-12-04 | 2016-03-09 | 南京美宁康诚生物科技有限公司 | 12种脑炎病毒核酸多重pcr检测试剂盒及其应用 |
CN105734164A (zh) * | 2016-05-06 | 2016-07-06 | 苏州大学 | 一种检测细菌性脑膜炎病原体的多重pcr试剂盒 |
CN110656192A (zh) * | 2019-11-08 | 2020-01-07 | 首都医科大学附属北京天坛医院 | 一种检测脑膜炎奈瑟氏菌的环介导等温扩增引物组及检测方法 |
CN110904253A (zh) * | 2019-12-18 | 2020-03-24 | 上海伯杰医疗科技有限公司 | 脑炎脑膜炎核酸分型检测试剂盒及检测方法 |
-
2020
- 2020-05-27 CN CN202010461604.1A patent/CN111455115A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1420123A (zh) * | 2001-11-16 | 2003-05-28 | 晶碁生化科技股份有限公司 | 用于诊断脑膜炎病原菌的核酸序列、方法及套组 |
CN102994650A (zh) * | 2012-06-21 | 2013-03-27 | 海尔施生物医药股份有限公司 | 一种基于毛细电泳的致脑炎病毒多重基因检测方法 |
CN103074448A (zh) * | 2013-01-25 | 2013-05-01 | 海尔施生物医药股份有限公司 | 一种同步检测二十三种脑炎脑膜炎病原体的试剂盒及其检测方法 |
CN105385787A (zh) * | 2015-12-04 | 2016-03-09 | 南京美宁康诚生物科技有限公司 | 12种脑炎病毒核酸多重pcr检测试剂盒及其应用 |
CN105734164A (zh) * | 2016-05-06 | 2016-07-06 | 苏州大学 | 一种检测细菌性脑膜炎病原体的多重pcr试剂盒 |
CN110656192A (zh) * | 2019-11-08 | 2020-01-07 | 首都医科大学附属北京天坛医院 | 一种检测脑膜炎奈瑟氏菌的环介导等温扩增引物组及检测方法 |
CN110904253A (zh) * | 2019-12-18 | 2020-03-24 | 上海伯杰医疗科技有限公司 | 脑炎脑膜炎核酸分型检测试剂盒及检测方法 |
Non-Patent Citations (3)
Title |
---|
WANG L等: "Development and validation of a multiplex-PCR based assay for the detection of 18 pathogens in the cerebrospinal fluid of hospitalized children with viral encephalitis", 《JOURNAL OF VIROLOGICAL METHODS》 * |
刘美真等: "广东省1例流行性脑脊髓膜炎死亡病例流行病学调查", 《疾病监测》 * |
陈倩倩: "急性病毒性脑炎及脑膜炎常见病毒实时荧光定量PCR检测方法的建立和应用", 《CNKI中国优秀硕士学位论文全文数据库,医药卫生科技辑,南华大学硕士学位论文》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114672593A (zh) * | 2022-03-25 | 2022-06-28 | 江苏先声医学诊断有限公司 | 用于中枢神经感染病原体核酸检测的引物组、产品及应用 |
CN114672593B (zh) * | 2022-03-25 | 2023-12-15 | 江苏先声医学诊断有限公司 | 用于中枢神经感染病原体核酸检测的引物组、产品及应用 |
CN116144811A (zh) * | 2022-12-21 | 2023-05-23 | 迪飞医学科技(南京)有限公司 | 用于检测脑脊液病原的多重引物组、方法和试剂盒 |
CN116144811B (zh) * | 2022-12-21 | 2024-02-20 | 迪飞医学科技(南京)有限公司 | 用于检测脑脊液病原的多重引物组、方法和试剂盒 |
CN116042921A (zh) * | 2022-12-28 | 2023-05-02 | 圣湘生物科技股份有限公司 | 检测病毒性脑炎病毒的组合物、试剂盒、方法及其用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111455115A (zh) | 一种基于rt-pcr及毛细电泳的同步检测19种脑炎脑膜炎病原体的试剂盒及检测方法 | |
CN105392896B (zh) | 快速并灵敏基因型鉴定及核酸检测 | |
CN103074448B (zh) | 一种同步检测二十三种脑炎脑膜炎病原体的试剂盒及其检测方法 | |
CN112226538B (zh) | 用于新型冠状病毒检测的引物探针组合、试剂盒及方法 | |
US20220411852A1 (en) | Composition for detecting pathogens, and kit and method therefor | |
CN114898808A (zh) | 一种预测肺炎克雷伯菌对头孢吡肟敏感性的方法及系统 | |
CN107955836A (zh) | 用于肺癌相关基因shox2甲基化检测的引物对、试剂盒及方法 | |
CN106434996A (zh) | 一种检测鲍曼不动杆菌dna的试剂盒及检测方法 | |
CN111763767A (zh) | 中枢神经系统感染病原体检测试剂盒及其应用 | |
CN114990260B (zh) | 用于检测中枢神经系统感染性病原体的多重荧光定量pcr检测试剂 | |
CN109355406B (zh) | 一种基于血液游离核酸的检测结核分枝杆菌的试剂盒 | |
Patel et al. | Assessment of the diagnostic utility of GeneXpert Mycobacterium tuberculosis/Rifampicin (MTB/RIF) assay in the suspected cases of tuberculous meningitis | |
Liu et al. | Clinical application value of metagenomic next-generation sequencing in the diagnosis of central nervous system infections | |
RU2299439C1 (ru) | Способ диагностики инфекционного мононуклеоза | |
CN111270008A (zh) | 一种细小病毒b19核酸定量检测试剂盒 | |
CN114836579B (zh) | 中枢神经系统感染性病原体的多重荧光定量pcr检测引物组合 | |
CN114672593B (zh) | 用于中枢神经感染病原体核酸检测的引物组、产品及应用 | |
CN116121409B (zh) | 一种多重qPCR检测细菌的探针引物组、试剂盒以及检测方法 | |
Bahceci | Epidemiology of Tuberculosis with comparison of the efficacy of culture, realtime PCR and direct microscopy in the diagnosis of tuberculosis | |
RU2819044C1 (ru) | Тест-система для выявления ДНК возбудителя моракселлеза KPC (Moraxella bovis) в биологическом материале животных и кормах с помощью полимеразной цепной реакции в режиме реального времени | |
CN114686586B (zh) | 一种用于诊断结核性胸膜炎的分子标志物组合物及其应用 | |
CN117385105A (zh) | 一种pcr检测试剂及方法和应用 | |
CN110195128B (zh) | 基于恒温核酸扩增技术的皮肤型hpv分型检测引物核苷酸序列及应用 | |
CN116855634A (zh) | 一种一体化快速检测中枢神经系统感染性疾病病原的核酸检测试剂盒 | |
Grantham et al. | 2296. Development of a Sequencing-Based Assay for Detection of CMV Antiviral Resistance Mutations to Letermovir in UL56 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Wu Yong Inventor after: Zeng Xianping Inventor after: Wang Weijian Inventor after: He Xiu Inventor after: Talent must be brilliant Inventor after: Kong Maimai Inventor after: Yu Ding Inventor before: Wu Yong Inventor before: Zeng Xianping Inventor before: Yu Daofu Inventor before: He Xiu Inventor before: Talent must be brilliant Inventor before: Kong Maimai Inventor before: Yu Ding |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wu Yong Inventor after: Zeng Xianping Inventor after: Wang Weijian Inventor after: He Xiu Inventor after: Talent must be brilliant Inventor after: Kong Maimai Inventor after: Yu Ding Inventor before: Wu Yong Inventor before: Zeng Xianping Inventor before: Wang Weijian Inventor before: He Xiu Inventor before: Talent must be brilliant Inventor before: Kong Maimai Inventor before: Yu Ding |
|
CB02 | Change of applicant information |
Address after: No.396, Mingzhu Road, science and Technology Park, Ningbo City, Zhejiang Province Applicant after: Ningbo Haier Shi Gene Technology Co.,Ltd. Address before: No.396, Mingzhu Road, science and Technology Park, Ningbo City, Zhejiang Province Applicant before: Ningbo Health Gene Technologies Co.,Ltd. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220408 Address after: 315000 No.396, Mingzhu Road, science and Technology Park, Ningbo City, Zhejiang Province Applicant after: Ningbo Haier Shi Gene Technology Co.,Ltd. Applicant after: Hebei children's Hospital Address before: No.396, Mingzhu Road, science and Technology Park, Ningbo City, Zhejiang Province Applicant before: Ningbo Haier Shi Gene Technology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200728 |
|
RJ01 | Rejection of invention patent application after publication |